Progyny, Inc. Capex per Share

Capex per Share of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex per Share growth rates and interactive chart. Capex per share refers to the total amount of capital expenditures paid in a period divided by the weighted average number of shares outstanding. If a company has capex of $100 million and 10 million shares outstanding, capex per share is $10.


Highlights and Quick Summary

  • Capex per Share for the quarter ending June 29, 2021 was -0.0 (a 16.67% increase compared to previous quarter)
  • Year-over-year quarterly Capex per Share increased by 188.24%
  • Annual Capex per Share for 2020 was -0.01 (a -65.82% decrease from previous year)
  • Annual Capex per Share for 2019 was -0.04 (a 405.71% increase from previous year)
  • Annual Capex per Share for 2018 was -0.01 (a -5.41% decrease from previous year)
  • Twelve month Capex per Share ending June 29, 2021 was -0.01 (a 45.12% increase compared to previous quarter)
  • Twelve month trailing Capex per Share decreased by -68.1% year-over-year
Trailing Capex per Share for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
-0.01 -0.01 -0.01 -0.04
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex per Share of Progyny, Inc.

Most recent Capex per Shareof PGNY including historical data for past 10 years.

Interactive Chart of Capex per Share of Progyny, Inc.

Progyny, Inc. Capex per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -0.0 -0.0
2020 -0.0 -0.0 -0.0 -0.01 -0.01
2019 -0.11 -0.06 -0.03 -0.02 -0.04
2018 0.0 -0.01 0.0 -0.01
2017 0.0 -0.01

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.